Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) FIGF Antibodies:
anti-Rat (Rattus) FIGF Antibodies:
anti-Human FIGF Antibodies:
Go to our pre-filtered search.
Human Monoclonal FIGF Primary Antibody for WB - ABIN387760
Romero, Friel, Velez Edwards, Kusanovic, Hassan, Mazaki-Tovi, Vaisbuch, Kim, Erez, Chaiworapongsa, Pearce, Bartlett, Salisbury, Anant, Vovis, Lee, Gomez, Behnke, Oyarzun, Tromp, Williams, Menon: A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). in American journal of obstetrics and gynecology 2010
Show all 6 references for ABIN387760
Human Polyclonal FIGF Primary Antibody for IHC (p), WB - ABIN967243
Yamada, Nezu, Shimane, Hirata: Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. in Genomics 1997
Show all 3 references for ABIN967243
Human Polyclonal FIGF Primary Antibody for EIA, IHC (p) - ABIN358813
Orlandini, Semboloni, Oliviero: Beta-catenin inversely regulates vascular endothelial growth factor-D mRNA stability. in The Journal of biological chemistry 2003
Show all 3 references for ABIN358813
Human Polyclonal FIGF Primary Antibody for EIA, WB - ABIN115681
Kirkin, Mazitschek, Krishnan, Steffen, Waltenberger, Pepper, Giannis, Sleeman: Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2. in European journal of biochemistry / FEBS 2001
Vegfd can compensate for loss of Vegfc (show VEGFC Antibodies) in zebrafish facial lymphatic sprouting.
VEGFD-mediated pathologies include or involve an underlying dysregulation of SOXF-mediated transcriptional networks.
Our studies therefore identified the first non-mammalian VEGF-D and established its in vivo role for vascular system development during vertebrate embryogenesis and provided an alternative animal model to further reveal functions of VEGF-D.
These results suggest that lymph node lymphangiogenesis occurs before metastasis in OSCC. VEGF-A (show VEGFA Antibodies) and VEGF-D play critical roles in this process.
Results provided evidence that IL-7 (show IL7 Antibodies)/IL-7R induce VEGF-D upregulation and promote lymphangiogenesis via c-Fos/c-Jun (show JUN Antibodies) pathway in lung cancer.
Epidermal keratinocyte proliferation in vitro was not affected by VEGF-C (show VEGFC Antibodies) or VEGF-D.
Neutrophils contribute to lymphangiogenesis primarily by modulating VEGF-A (show VEGFA Antibodies) bioavailability and bioactivity and, to a lesser extent, secreting VEGF-D. Neutrophils increased VEGF-A (show VEGFA Antibodies) bioavailability and bioactivity via the secretion of MMP9 (show MMP9 Antibodies) and heparanase (show HPSE Antibodies).
Vegf-d deficiency alters the caliber of initial lymphatics in the dermis leading to reduced functional capacity.
Vascular endothelial growth factor-C (show VEGFC Antibodies) and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction.
VEGF-D has a role in progestin-induced break-through bleeding in thin-walled blood and lymphatic endometrial vessels
nuclear calcium-VEGFD signaling mediates the effect of neuronal activity on the maintenance of dendritic arbors in the adult hippocampus and is required for cognitive functioning.
Data show that that OUBC induces profound lymphangiogenesis in the tumor and SLN (show SLN Antibodies) and substantial lymphatic metastasis to SLN (show SLN Antibodies) through VEGF-C (show VEGFC Antibodies)/D-VEGFR-3 (show FLT4 Antibodies) signaling pathway.
VEGF-D over-expression has differential effects on the uterine vasculature. These effects may facilitate VEGF-D's ability to promote endometrial cancer metastasis and disease progression.
The most extensively accepted signaling pathways promoting lymphangiogenesis in tumors include the secreted lymphangiogenic proteins: VEGF-C (show VEGFC Antibodies) and VEGF-D, and their cognate receptor on lymphatic endothelium VEGF receptor (show FLT1 Antibodies)-3 (VEGFR-3 (show FLT4 Antibodies)).
Study demonstrated that VEGF-D upregulates myofibroblast proliferation, migration, and collagen synthesis through activation of VEGF pathway.
MTA1 (show MTA1 Antibodies) is up-regulated in CRC (show CALR Antibodies); its expression is inversely associated with lymphatic metastases and the expression of VEGFC (show VEGFC Antibodies), VEGFD and VEGFR3 (show FLT4 Antibodies)
VEGF-C (show VEGFC Antibodies)/D score correlated neither with periphery Lymphatic vessel density (LVD) nor with LVD in the tumor center
study suggests that both VEGF-C (show VEGFC Antibodies) and VEGF-D in tumor cells promote lymph node metastasis
A positive association for VEGF-D and an inverse association for MMP-2 (show MMP2 Antibodies) were observed in patients with positive lymph node status at the time of radical cystectomy in urothelial carcinoma of the bladder.
These findings suggest that IL-8 (show IL8 Antibodies) may be a potent inducer of LECs, although this effect does not appear to involve the VEGF-C (show VEGFC Antibodies)/VEGF-D and VEGFR-3 (show FLT4 Antibodies) signaling pathway.
fluid shear stress induces the synthesis of Insulin growth factor-2 and vascular endothelial growth factor (VEGF) B and D, which in turn transactivate MMP-12.
Among VEGF (show VEGFA Antibodies) homologs, MMPE from various kinds of tumor origin, VEGF-D showed 92.6% rate of positive expression. ICC stain of VEGF-D is a useful marker in the aid of MMPE diagnosis.
VEGF-D is involved in the development of lymphangiogenesis in peritoneal dialysis patients.
The protein encoded by this gene is a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth. This secreted protein undergoes a complex proteolytic maturation, generating multiple processed forms which bind and activate VEGFR-2 and VEGFR-3 receptors. This protein is structurally and functionally similar to vascular endothelial growth factor C. Read-through transcription has been observed between this locus and the upstream PIR (GeneID 8544) locus.
c-fos induced growth factor (vascular endothelial growth factor D)
, vascular endothelial growth factor D
, vascular enthelial growth factor D
, vegf d
, Vascular endothelial growth factor D
, c-fos-induced growth factor